RENAU.UNSP.ARD 1/5 EO-20 - Asset Resilience Ratio

Latest as of March 2026: 0.32%

RENAU.UNSP.ARD 1/5 EO-20 (56S0) has an Asset Resilience Ratio of 0.32% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€26.20 Million
≈ $30.63 Million USD Cash + Short-term Investments

Total Assets

€8.19 Billion
≈ $9.57 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2022–2025)

This chart shows how RENAU.UNSP.ARD 1/5 EO-20's Asset Resilience Ratio has changed over time. See how financially flexible is RENAU.UNSP.ARD 1/5 EO-20 to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down RENAU.UNSP.ARD 1/5 EO-20's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see RENAU.UNSP.ARD 1/5 EO-20 market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €26.20 Million 0.32%
Total Liquid Assets €26.20 Million 0.32%

Asset Resilience Insights

  • Limited Liquidity: RENAU.UNSP.ARD 1/5 EO-20 maintains only 0.32% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

RENAU.UNSP.ARD 1/5 EO-20 Industry Peers by Asset Resilience Ratio

Compare RENAU.UNSP.ARD 1/5 EO-20's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Eyebright Medical Technology Beijing Co Ltd
SHG:688050
Medical Instruments & Supplies 1.51%
Autek China Inc
SHE:300595
Medical Instruments & Supplies 21.20%
Jiangsu Apon Medical Technology Co Ltd Class A
SHE:300753
Medical Instruments & Supplies 1.44%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%
Ocumetics Technology Corp
V:OTC
Medical Instruments & Supplies 0.00%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%

Annual Asset Resilience Ratio for RENAU.UNSP.ARD 1/5 EO-20 (2022–2025)

The table below shows the annual Asset Resilience Ratio data for RENAU.UNSP.ARD 1/5 EO-20.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.10% €8.10 Million
≈ $9.47 Million
€7.98 Billion
≈ $9.33 Billion
-0.02pp
2024-12-31 0.12% €9.90 Million
≈ $11.57 Million
€8.26 Billion
≈ $9.65 Billion
0.00pp
2023-12-31 0.12% €9.50 Million
≈ $11.11 Million
€7.73 Billion
≈ $9.04 Billion
-0.39pp
2022-12-31 0.51% €25.90 Million
≈ $30.28 Million
€5.07 Billion
≈ $5.92 Billion
--
pp = percentage points

About RENAU.UNSP.ARD 1/5 EO-20

F:56S0 Germany Medical Instruments & Supplies
Market Cap
$19.33 Billion
€16.54 Billion EUR
Market Cap Rank
#1606 Global
#347 in Germany
Share Price
€17.00
Change (1 day)
+0.59%
52-Week Range
€14.60 - €21.80
All Time High
€35.31
About

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more